Page last updated: 2024-08-21

cyclopentane and carbobenzoxy-leucyl-leucyl-norvalinal

cyclopentane has been researched along with carbobenzoxy-leucyl-leucyl-norvalinal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, K; Koide, T; Kozuki, D; Omura, S; Shirotani, H; Tokunaga, F1

Other Studies

1 other study(ies) available for cyclopentane and carbobenzoxy-leucyl-leucyl-norvalinal

ArticleYear
Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors.
    FEBS letters, 1997, Jul-21, Volume: 412, Issue:1

    Topics: Acetylcysteine; Animals; Antithrombin III; Brefeldin A; Cell Line; Cricetinae; Cyclopentanes; Cysteine Endopeptidases; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Enzyme Inhibitors; Fluorescent Antibody Technique; Golgi Apparatus; Humans; Kidney; Leupeptins; Multienzyme Complexes; Mutagenesis, Site-Directed; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Synthesis Inhibitors; Transfection

1997